• ClipSaver
ClipSaver
Русские видео
  • Смешные видео
  • Приколы
  • Обзоры
  • Новости
  • Тесты
  • Спорт
  • Любовь
  • Музыка
  • Разное
Сейчас в тренде
  • Фейгин лайф
  • Три кота
  • Самвел адамян
  • А4 ютуб
  • скачать бит
  • гитара с нуля
Иностранные видео
  • Funny Babies
  • Funny Sports
  • Funny Animals
  • Funny Pranks
  • Funny Magic
  • Funny Vines
  • Funny Virals
  • Funny K-Pop

Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering скачать в хорошем качестве

Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering 3 months ago

video

sharing

camera phone

video phone

free

upload

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering
  • Поделиться ВК
  • Поделиться в ОК
  •  
  •  


Скачать видео с ютуб по ссылке или смотреть без блокировок на сайте: Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering в качестве 4k

У нас вы можете посмотреть бесплатно Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering или скачать в максимальном доступном качестве, видео которое было загружено на ютуб. Для загрузки выберите вариант из формы ниже:

  • Информация по загрузке:

Скачать mp3 с ютуба отдельным файлом. Бесплатный рингтон Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering в формате MP3:


Если кнопки скачивания не загрузились НАЖМИТЕ ЗДЕСЬ или обновите страницу
Если возникают проблемы со скачиванием видео, пожалуйста напишите в поддержку по адресу внизу страницы.
Спасибо за использование сервиса ClipSaver.ru



Tackling heterogeneity in Sjögren’s disease: the role of stratification and clustering

This ERN ReCONNET webinar focuses on the stratification of patients with Sjögren's disease. Sjögren's disease is an autoimmune disease with heterogeneous manifestations, ranging from dry syndrome, fatigue and pain to systemic cutaneous, renal, neurological and hematological manifestations and the risk of lymphoma. For the moment, very few treatments have been shown to be effective, sometimes because of the choice of evaluation, but also perhaps because the populations included were too heterogeneous. Tackling the heterogeneity of patients with Sjögren's disease is therefore a major challenge, both for designing clinical studies and for understanding the disease. Some teams have proposed stratifying patients according to their symptoms. More recently, a new stratification of patients has been proposed, taking into account not only symptoms but also systemic manifestations and the main biological data. This has given rise to 3 sub-groups, or "clusters" of patients: the BALS cluster (B-cell active with low symptoms), the HSA cluster (high systemic activity) and the LSAHS cluster (low systemic activity with high symptoms). These different groups differ not only in their characteristics but also in their prognosis and evolution. In addition, these sub-groups have different cytokine profiles, particularly with regard to B and T-cell activities and the interferon signature, suggesting different pathophysiological mechanisms. The speaker of this webinar is Dr. Yann Nguyen from the Université Paris Cité, Assistance Publique, Hôpitaux de Paris. The moderators of this webinar are Prof. Gaetane Nocturne (APHP Hopital Bicetre, Paris Saclay University, INSERM) and Coralie Bouillot (Sjogren Europe). Yann Nguyen is an associate professor in Internal Medicine and Clinical Immunology at Paris Cité University. He holds an MD and a PhD in public health. He has worked for many years with the Autoimmune Diseases Reference Centre, Rheumatology Department, Bicêtre Hospital, Paris Saclay University, with Professor Xavier Mariette, Professor Raphaèle Seror and Professor Gaetane Nocturne. His research focuses on the epidemiology of immune-mediated inflammatory diseases, in particular the risk factors for rheumatoid polyarhtritis, lupus and vasculitis, and more recently on the stratification of patients with Sjögren's disease. He is the author of over 80 publications. More info about Sjogren’s disease can be found here: https://reconnet.ern-net.eu/disease-ss/ You can register to the ERN ReCONNET Newsletter at the following link: https://reconnet.ern-net.eu/subscribe...

Comments
  • Diagnosis and management of peripheral neurological manifestations in Sjögren’s disease 1 month ago
    Diagnosis and management of peripheral neurological manifestations in Sjögren’s disease
    Опубликовано: 1 month ago
    313
  • From basics to updates for cutaneous lupus erythematosus (CLE) 2 days ago
    From basics to updates for cutaneous lupus erythematosus (CLE)
    Опубликовано: 2 days ago
    111
  • How to explain the antiphospholipid profile to my patients? 8 months ago
    How to explain the antiphospholipid profile to my patients?
    Опубликовано: 8 months ago
    375
  • Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024? 6 months ago
    Screening and treatment of systemic sclerosis-associated PAH: where do we stand in 2024?
    Опубликовано: 6 months ago
    323
  • 432Hz- Fall Into Deep Healing Sleep, Regenerates Body and Mind, Emotional and Physical Healing
    432Hz- Fall Into Deep Healing Sleep, Regenerates Body and Mind, Emotional and Physical Healing
    Опубликовано:
    0
  • Introduction to the immune system 1 year ago
    Introduction to the immune system
    Опубликовано: 1 year ago
    291460
  • Brain Tumors 6 years ago
    Brain Tumors
    Опубликовано: 6 years ago
    401205
  • How 'ignorant' Trump's China talks put president in 'weak position' | David Cay Johnston 4 days ago
    How 'ignorant' Trump's China talks put president in 'weak position' | David Cay Johnston
    Опубликовано: 4 days ago
    247395
  • Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025? 2 months ago
    Treatment of systemic sclerosis-associated interstitial lung disease: where do we stand in 2025?
    Опубликовано: 2 months ago
    460
  • Obstetric manifestations in past and present antiphospholipid syndrome (APS) classification criteria 1 month ago
    Obstetric manifestations in past and present antiphospholipid syndrome (APS) classification criteria
    Опубликовано: 1 month ago
    158

Контактный email для правообладателей: [email protected] © 2017 - 2025

Отказ от ответственности - Disclaimer Правообладателям - DMCA Условия использования сайта - TOS